Vydate 24 L

Primær information

  • Handelsnavn:
  • Vydate 24 L Flydende middel
  • Lægemiddelform:
  • Flydende middel
  • Sammensætning:
  • 240 g/l oxamyl
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

Lokation

  • Fås i:
  • Vydate 24 L Flydende middel
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Sidste ændring:
  • 08-02-2018

Produktresumé

SAFETY DATA SHEET

according to EC directive 2001/58/EC

Vydate

®

L (blue)

Version 2.0

Revision Date 11.01.2005

Ref. 130000013373

This SDS adheres to the standards and regulatory requirements of the European Community and may not meet the

regulatory requirements of other countries.

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

Product information

Product name

Vydate

L (blue)

Synonyms

B10067501

Use of the

Substance/Preparation

insecticide

Company

Du Pont de Nemours (France) S.A.S.

Rue de L'Université 137

75334 Paris

+330145506550

Telefax

Emergency telephone

number

+44-(0)2871-861.313

2. COMPOSITION/INFORMATION ON INGREDIENTS

Chemical nature of the

preparation

Carbamate in aqueous methanol solution

Chemical Name

CAS-No.

EC-No.

Classification

Concentration [%]

Methanol

67-56-1

200-659-6

F; R11

T; R23/24/25

R39/23/24/25

30 - 50

Oxamyl

23135-22-0

T+; R26/28

Xn; R21

N; R51

For the full text of the R phrases mentioned in this Section, see Section 16.

3. HAZARDS IDENTIFICATION

Flammable.

Toxic by inhalation and if swallowed.

Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed.

Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.

4. FIRST AID MEASURES

General advice

Call a physician or Poison Control Centre immediately. This product contains an

anticholinesterase compound. Do not use if under medical advice not to work

with such compounds. Never give anything by mouth to an unconscious person.

If breathing is irregular or stopped, administer artificial respiration.

Print Date: 2006 - 5 - 16

SAFETY DATA SHEET

according to EC directive 2001/58/EC

Vydate

®

L (blue)

Version 2.0

Revision Date 11.01.2005

Ref. 130000013373

Inhalation

Move to fresh air. If victim is unconscious but breathing: Give oxygen.

Skin contact

Wash off immediately with soap and plenty of water. Take off contaminated

clothing and shoes immediately.

Eye contact

Rinse thoroughly with plenty of water, also under the eyelids. Keep eye wide

open while rinsing. If eye irritation persists, consult a specialist.

Ingestion

Drink 1 or 2 glasses of water. Do not induce vomiting without medical advice.

Notes to physician

Symptoms

constriction of pupils, blurred vision, weakness, headache, Daze, sweating,

muscle twitching, Breathing difficulties

Risks

This product is a cholinesterase inhibitor carbamate.

Treatment

Administer atropine sulphate as antidote. bis zur völligen Atropisierung

Morphine, 2-PAM and oxime therapy are contra-indicated.

5. FIRE-FIGHTING MEASURES

Suitable extinguishing

media

water spray, dry chemical, foam, carbon dioxide (CO2),

Extinguishing media which

must not be used for safety

reasons

high volume water jet, (contamination risk),

Special protective

equipment for fire-fighters

In the event of fire, wear self-contained breathing apparatus.

Further information

In the event of fire and/or explosion do not breathe fumes. (on small fires) If area

is heavily exposed to fire and if conditions permit, let fire burn itself out since

water may increase the area contaminated. Cool containers / tanks with water

spray.

6. ACCIDENTAL RELEASE MEASURES

Personal precautions

Wear personal protective equipment. Evacuate personnel to safe areas.

Environmental precautions

Do not flush into surface water or sanitary sewer system. Do not contaminate

surface water. Do not allow material to contaminate ground water system.

Methods for cleaning up

Neutralise with sodium hydroxide and allow to stand for 4 hours. Soak up with

inert absorbent material. If liquid has been spilt in large quantities clean up

promptly by scoop or vacuum. Use approved industrial vacuum cleaner for

removal. Shovel into suitable container for disposal.

7. HANDLING AND STORAGE

Handling

Print Date: 2006 - 5 - 16

SAFETY DATA SHEET

according to EC directive 2001/58/EC

Vydate

®

L (blue)

Version 2.0

Revision Date 11.01.2005

Ref. 130000013373

Advice on safe handling

Provide adequate ventilation. Wear personal protective equipment.

Advice on protection

against fire and explosion

Keep away from heat and sources of ignition.

Storage

Requirements for storage

areas and containers

Keep containers tightly closed in a dry, cool and well-ventilated place. Store in a

place accessible by authorized persons only. Keep out of the reach of children.

Advice on common storage

No materials to be especially mentioned.

Storage temperature

> 0 °C

Other data

: Do not freeze.

8. EXPOSURE CONTROLS / PERSONAL PROTECTION

Engineering measures

Ensure adequate ventilation, especially in confined areas.

Personal protective equipment

Respiratory protection

Respirator with combination filter for vapour/particulate. respirator with A2B2-P3

filter

Hand protection

Material: solvent-resistant gloves (butyl-rubber)

Glove thickness: 0,4 - 0,7 mm

Wearing time: 480 min

Please observe the instructions regarding permeability and breakthrough time

which are provided by the supplier of the gloves. Also take into consideration the

specific local conditions under which the product is used, such as the danger of

cuts, abrasion, and the contact time.

Eye protection

face-shield tightly fitting safety goggles

Skin and body protection

protective suit

Hygiene measures

Wash hands before breaks and immediately after handling the product. Keep

away from food, drink and animal feeding stuffs. When using, do not eat, drink

or smoke. Remove and wash contaminated clothing and gloves, including the

inside, before re-use.

Protective measures

All chemical protective clothing should be visually inspected prior to use.

Clothing and gloves should be replaced in case of chemical or physical damage

or if contaminated.

9. PHYSICAL AND CHEMICAL PROPERTIES

Form

liquid,

Print Date: 2006 - 5 - 16

SAFETY DATA SHEET

according to EC directive 2001/58/EC

Vydate

®

L (blue)

Version 2.0

Revision Date 11.01.2005

Ref. 130000013373

Colour

blue,

Odour

slight, sulphurous,

2,8 - 3,2 at 10 g/l ( 20 °C)

Solidification point

-5 °C

Flash point

23 °C , Method: closed cup

Flash point

30 °C , Method: open cup

Density

0,98 g/cm3 at 25 °C

Solubility/qualitative

completely miscible

Partition coefficient (n-

octanol/water)

POW: 0,33 log Pow: -0,48

Viscosity, dynamic

1 - 5 mPa/s at 20 °C, see user defined free text

10. STABILITY AND REACTIVITY

Conditions to avoid

: Processing temperature : > 130 °C

Hazardous decomposition

products

: Carbon oxides, nitrogen oxides (NOx), Heating can release vapours which can

be ignited.

Hazardous reactions

: Vapours may form explosive mixture with air. No decomposition if stored and

applied as directed.

11. TOXICOLOGICAL INFORMATION

Acute oral toxicity

LD50/rat male: 37 mg/kg

Acute oral toxicity

Methanol

LD50/rat : 5 628 mg/kg

Acute inhalation toxicity

LC50/1 h/rat : 0,3009 mg/l

Acute inhalation toxicity

Methanol

LC50/4 h/rat : 50 mg/l

Acute dermal toxicity

LD50/rat : > 5 000 mg/kg

Acute dermal toxicity

Methanol

LD50/rat : 15 800 mg/kg

Skin irritation

No skin irritation

Print Date: 2006 - 5 - 16

SAFETY DATA SHEET

according to EC directive 2001/58/EC

Vydate

®

L (blue)

Version 2.0

Revision Date 11.01.2005

Ref. 130000013373

Eye irritation

No eye irritation

Sensitization

Did not cause sensitization on laboratory animals.

Repeated dose toxicity

Methanol

Inhalation rat, Exposure time: 90 d, NOEL: 13,3 mg/l

12. ECOLOGICAL INFORMATION

Elimination information (persistence and degradability)

Biodegradability

According to the results of tests of biodegradability this product is considered as

being readily biodegradable.

Ecotoxicity effects

Toxicity to fish

LC50/96 h/Oncorhynchus mykiss (rainbow trout): 12,4 mg/l

Toxicity to fish

Methanol

LC50/96 h/Fathead minnow: 28 100 mg/l

Aquatic toxicity

EC50/48 h/Daphnia: 1,95 mg/l

13. DISPOSAL CONSIDERATIONS

Product

In accordance with local and national regulations. Must be incinerated in a

suitable incineration plant holding a permit delivered by the competent

authorities. The product should not be allowed to enter drains, water courses or

the soil.

14. TRANSPORT INFORMATION

ADR

Class:

Packaging group:

Classification Code:

HI No::

UN-No:

2991

Labelling No.:

6.1, 3

Proper shipping name:

Carbamate pesticide, liquid, toxic, flammable (Oxamyl, Methanol)

IATA_C

Class:

Packaging group:

UN-No:

2991

Labelling No.:

6.1, 3

Print Date: 2006 - 5 - 16

SAFETY DATA SHEET

according to EC directive 2001/58/EC

Vydate

®

L (blue)

Version 2.0

Revision Date 11.01.2005

Ref. 130000013373

Proper shipping name:

Carbamate pesticide, liquid, toxic, flammable (Oxamyl, Methanol)

IMDG

Class:

Packaging group:

UN-No:

2991

Labelling No.:

6.1, 3

Proper shipping name:

Carbamate pesticide, liquid, toxic, flammable (Oxamyl, Methanol)

15. REGULATORY INFORMATION

Labelling according to EC Directives

Symbol(s)

Toxic

Dangerous for the environment

Hazardous components:

Methanol

Oxamyl

R-phrase(s)

Flammable.

R23/25

Toxic by inhalation and if swallowed.

R39/23/24/25

Toxic: danger of very serious irreversible effects through

inhalation, in contact with skin and if swallowed.

R51/53

Toxic to aquatic organisms, may cause long-term adverse

effects in the aquatic environment.

S-phrase(s)

Keep out of reach of children.

Keep away from food, drink and animal feeding stuffs.

S20/21

When using do not eat, drink or smoke.

This material and its container must be disposed of in a safe

way.

S36/37

Wear suitable protective clothing and gloves.

In case of accident or if you feel unwell, seek medical advice

immediately (show the label where possible).

Use appropriate container to avoid environmental

contamination.

Exceptional labelling of

special preparations

To avoid risks to man and the environment, comply with the instructions for use.

16. OTHER INFORMATION

Text of R phrases mentioned in Section 2

Print Date: 2006 - 5 - 16

SAFETY DATA SHEET

according to EC directive 2001/58/EC

Vydate

®

L (blue)

Version 2.0

Revision Date 11.01.2005

Ref. 130000013373

Highly flammable.

Harmful in contact with skin.

R23/24/25

Toxic by inhalation, in contact with skin and if swallowed.

R26/28

Also very toxic by inhalation and if swallowed.

R39/23/24/25

Toxic: danger of very serious irreversible effects through inhalation, in contact with skin

and if swallowed.

Toxic to aquatic organisms.

May cause long-term adverse effects in the aquatic environment.

The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at

the date of its publication. The information given is designed only as a guidance for safe handling, use, processing,

storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The

information relates only to the specific material designated and may not be valid for such material used in

combination with any other materials or in any process, unless specified in the text.

Print Date: 2006 - 5 - 16

  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.



  • Dokumenter på andre sprog er tilgængelige her

24-1-2018

Enforcement Report for the Week of January 24, 2018

Enforcement Report for the Week of January 24, 2018

FDA - U.S. Food and Drug Administration

24-5-2017

Enforcement Report for the Week of May 24, 2017

Enforcement Report for the Week of May 24, 2017

FDA - U.S. Food and Drug Administration

30-11-2016

Twelve new substances on the list of euphoriant substances

Twelve new substances on the list of euphoriant substances

As of 24 November 2016, 12 new substances are included in the Danish executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health. The information is primarily relevant to companies authorised to deal with euphoriant substances.

Danish Medicines Agency

24-8-2016

Enforcement Report for the Week of August 24, 2016

Enforcement Report for the Week of August 24, 2016

FDA - U.S. Food and Drug Administration

24-2-2016

Enforcement Report for the Week of February 24, 2016

Enforcement Report for the Week of February 24, 2016

FDA - U.S. Food and Drug Administration

24-6-2015

Enforcement Report for the Week of June 24, 2015

Enforcement Report for the Week of June 24, 2015

FDA - U.S. Food and Drug Administration

24-12-2014

Enforcement Report for the Week of December 24, 2014

Enforcement Report for the Week of December 24, 2014

FDA - U.S. Food and Drug Administration

3-10-2014

Consultation procedure about medicinal products and safety measure requirements not completed yet

Consultation procedure about medicinal products and safety measure requirements not completed yet

On 5 September 2014, the Danish Health and Medicines Authority submitted a draft list of the medicinal products comprised by the new safety measures rules (Directive 2001/83) for consultation. The consultation period expired on 17 September 2014, and on 3 October we were to inform the European Commission of the medicinal products we recommend including in the common EU lists. We have received 22 consultation responses. But on 24 September 2014 the European Commission amended the original guideline for...

Danish Medicines Agency

24-9-2014

Enforcement Report for the Week of September 24, 2014

Enforcement Report for the Week of September 24, 2014

FDA - U.S. Food and Drug Administration

24-7-2013

Enforcement Report for the Week of July 24, 2013

Enforcement Report for the Week of July 24, 2013

FDA - U.S. Food and Drug Administration

24-4-2013

Enforcement Report for the Week of April 24, 2013

Enforcement Report for the Week of April 24, 2013

FDA - U.S. Food and Drug Administration

24-10-2012

Enforcement Report for the Week of October 24, 2012

Enforcement Report for the Week of October 24, 2012

FDA - U.S. Food and Drug Administration

31-7-2012

Danish Pharmacovigilance Update, 24 May 2012

Danish Pharmacovigilance Update, 24 May 2012

Among the topics covered in this issue of Danish Pharmacovigilance Update are: Drug Analysis Prints involving data from more than 14,000 Danish adverse reaction reports available at the Danish Health and Medicines Authority’s website.

Danish Medicines Agency

10-7-2018

 Minutes - PDCO minutes of the 24-27 April 2018 meeting

Minutes - PDCO minutes of the 24-27 April 2018 meeting

Europe - EMA - European Medicines Agency

11-6-2018

Zykadia (Novartis Europharm Limited)

Zykadia (Novartis Europharm Limited)

Zykadia (Active substance: ceritinib) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3758 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3819/T/24

Europe -DG Health and Food Safety

28-5-2018

Vipdomet (Takeda Pharma A/S)

Vipdomet (Takeda Pharma A/S)

Vipdomet (Active substance: alogliptin / metformin) - Centralised - Renewal - Commission Decision (2018)3346 of Mon, 28 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2654/R/24

Europe -DG Health and Food Safety

24-5-2018

#ThrowBackThursday- May 24, 1977- Bureau of Medical Devices and Diagnostic Products renamed Bureau of Medical Devices and new Office of Small Manufacturers Assistance created, as required by law. #OnThisDay #FDAHistory

#ThrowBackThursday- May 24, 1977- Bureau of Medical Devices and Diagnostic Products renamed Bureau of Medical Devices and new Office of Small Manufacturers Assistance created, as required by law. #OnThisDay #FDAHistory

#ThrowBackThursday- May 24, 1977- Bureau of Medical Devices and Diagnostic Products renamed Bureau of Medical Devices and new Office of Small Manufacturers Assistance created, as required by law. #OnThisDay #FDAHistory

FDA - U.S. Food and Drug Administration

24-5-2018

Tybost (Gilead Sciences International Limited)

Tybost (Gilead Sciences International Limited)

Tybost (Active substance: cobicistat) - PSUSA - Modification - Commission Decision (2018)3255 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10081/201708

Europe -DG Health and Food Safety

24-5-2018

Ultibro Breezhaler (Novartis Europharm Limited)

Ultibro Breezhaler (Novartis Europharm Limited)

Ultibro Breezhaler (Active substance: indacaterol/glycopyrronium bromide) - Centralised - Renewal - Commission Decision (2018)3259 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2679/R/24

Europe -DG Health and Food Safety

24-5-2018

Jylamvo (Therakind Ltd)

Jylamvo (Therakind Ltd)

Jylamvo (Active substance: methotrexate) - PSUSA - Modification - Commission Decision (2018)3263 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2014/201706

Europe -DG Health and Food Safety

24-5-2018

Pemetrexed Krka (KRKA, d.d., Novo mesto)

Pemetrexed Krka (KRKA, d.d., Novo mesto)

Pemetrexed Krka (Active substance: pemetrexed) - Centralised - Authorisation - Commission Decision (2018)3278 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3958

Europe -DG Health and Food Safety

24-5-2018

Osseor (Les Laboratoires Servier)

Osseor (Les Laboratoires Servier)

Osseor (Active substance: Strontium ranelate) - PASS - Modification - Commission Decision (2018)3271 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSR/S/13

Europe -DG Health and Food Safety

24-5-2018

Protelos (Les Laboratoires Servier)

Protelos (Les Laboratoires Servier)

Protelos (Active substance: Strontium ranelate) - PASS - Modification - Commission Decision (2018)3270 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSR/S/13

Europe -DG Health and Food Safety

24-5-2018

Ristaben (Merck Sharp and Dohme Limited)

Ristaben (Merck Sharp and Dohme Limited)

Ristaben (Active substance: sitagliptin) - PSUSA - Modification - Commission Decision (2018)3258 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2711/201708

Europe -DG Health and Food Safety

24-5-2018

Velmetia (Merck Sharp and Dohme Limited)

Velmetia (Merck Sharp and Dohme Limited)

Velmetia (Active substance: sitagliptin / metformin hydrochloride) - PSUSA - Modification - Commission Decision (2018)3261 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2003/201708

Europe -DG Health and Food Safety

24-5-2018

Ristfor (Merck Sharp and Dohme Limited)

Ristfor (Merck Sharp and Dohme Limited)

Ristfor (Active substance: sitagliptin / metformin hydrochloride) - PSUSA - Modification - Commission Decision (2018)3262 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2003/201708

Europe -DG Health and Food Safety

24-5-2018

Janumet (Merck Sharp and Dohme Limited)

Janumet (Merck Sharp and Dohme Limited)

Janumet (Active substance: sitagliptin / metformin hydrochloride) - PSUSA - Modification - Commission Decision (2018)3260 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2003/201708

Europe -DG Health and Food Safety

24-5-2018

Efficib (Merck Sharp and Dohme Limited)

Efficib (Merck Sharp and Dohme Limited)

Efficib (Active substance: sitagliptin / metformin hydrochloride) - PSUSA - Modification - Commission Decision (2018)3276 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2003/201708

Europe -DG Health and Food Safety

24-5-2018

Bosulif (Pfizer Limited)

Bosulif (Pfizer Limited)

Bosulif (Active substance: Bosutinib) - Centralised - Variation - Commission Decision (2018)3269 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2373/X/26

Europe -DG Health and Food Safety

24-5-2018

Xoterna Breezhaler (Novartis Europharm Limited)

Xoterna Breezhaler (Novartis Europharm Limited)

Xoterna Breezhaler (Active substance: indacaterol/glycopyrronium bromide) - Centralised - Renewal - Commission Decision (2018)3265 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3755/R/27

Europe -DG Health and Food Safety

24-5-2018

Stivarga (Bayer AG)

Stivarga (Bayer AG)

Stivarga (Active substance: regorafenib) - Centralised - Renewal - Commission Decision (2018)3266 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2573/R/25

Europe -DG Health and Food Safety

24-5-2018

Tesavel (Merck Sharp and Dohme Limited)

Tesavel (Merck Sharp and Dohme Limited)

Tesavel (Active substance: sitagliptin) - PSUSA - Modification - Commission Decision (2018)3256 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2711/201708

Europe -DG Health and Food Safety

24-5-2018

Pedea (Orphan Europe S.A.R.L.)

Pedea (Orphan Europe S.A.R.L.)

Pedea (Active substance: Ibuprofen) - PSUSA - Modification - Commission Decision (2018)3257 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/1712/201707

Europe -DG Health and Food Safety

24-5-2018

Stribild (Gilead Sciences International Limited)

Stribild (Gilead Sciences International Limited)

Stribild (Active substance: elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)) - PSUSA - Modification - Commission Decision (2018)3277 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2574/PSUSA/10082/201708

Europe -DG Health and Food Safety

24-5-2018

Xarelto (Bayer AG)

Xarelto (Bayer AG)

Xarelto (Active substance: rivaroxaban) - Centralised - Renewal - Commission Decision (2018)3264 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/944/R/60

Europe -DG Health and Food Safety

24-5-2018

Xelevia (Merck Sharp and Dohme Limited)

Xelevia (Merck Sharp and Dohme Limited)

Xelevia (Active substance: sitagliptin) - PSUSA - Modification - Commission Decision (2018)3275 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/762/PSUSA/2711/20178

Europe -DG Health and Food Safety

24-5-2018

Tyverb (Novartis Europharm Limited)

Tyverb (Novartis Europharm Limited)

Tyverb (Active substance: lapatinib) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3273 of Thu, 24 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/795/T/52

Europe -DG Health and Food Safety

22-5-2018

Agenda:  Agenda - COMP agenda of the 22-24 May 2018 meeting

Agenda: Agenda - COMP agenda of the 22-24 May 2018 meeting

Europe - EMA - European Medicines Agency

15-5-2018

Ulunar Breezhaler (Novartis Europharm Limited)

Ulunar Breezhaler (Novartis Europharm Limited)

Ulunar Breezhaler (Active substance: indacaterol/glycopyrronium bromide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3058 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3875/T/24

Europe -DG Health and Food Safety

24-11-2017

Gadolinium

Gadolinium

Gadolinium (Active substance: gadodiamide, gadopentetic acid, gadobenic acid, gadoxetic acid, gadoteridol, gadobutrol and gadoteric acid) - Community Referrals - Art 31 - Commission Decision (2017)7941 of Fri, 24 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/A-31/1437

Europe -DG Health and Food Safety